Centogene
Alva Rani James, PhD, currently serves as a Senior Bioinformatics Scientist at CENTOGENE, specializing in pharma business operations and the development of data products leveraging omics and real-world evidence datasets. Noteworthy contributions include the application of generative AI for RWD data generation and implementation of data transformation techniques through various ETL approaches. Alva also holds a position as a Bioinformatics Consultant at AlphaSights while previously working as a Postdoctoral Researcher at Hasso Plattner Institute, focusing on deep learning in cancer genomics. Alva's extensive experience includes roles as a Data Analyst at ETH Zurich, Bioinformatician at CHARITE UNIVERSITATSMEDIZIN BERLIN, and in various capacities within major research institutions, highlighting expertise in bioinformatics, machine learning, and pipeline development. Academic credentials include a PhD in Molecular Medicine from Charité - Universitätsmedizin Berlin, a Master’s degree in Bioinformatics from Chalmers University of Technology, and a Bachelor's degree in Bioinformatics.
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.